menu
    • menu

    Company profile for Immune Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Immune Therapeutics, Inc. is a pioneering pharmaceutical company involved in the acquisition, development, and commercialization of pharmaceutical and biotechnology products that have a well-defined path to market. By utilizing a biotech portfolio hub-and-spoke engine, we plan to advance focused and efficient small-scale biotechnology and pharmaceutical programs through subsidiaries, investment vehicles or partnerships, and de...
    Immune Therapeutics, Inc. is a pioneering pharmaceutical company involved in the acquisition, development, and commercialization of pharmaceutical and biotechnology products that have a well-defined path to market. By utilizing a biotech portfolio hub-and-spoke engine, we plan to advance focused and efficient small-scale biotechnology and pharmaceutical programs through subsidiaries, investment vehicles or partnerships, and deploy products from those programs in markets both in the U.S. and internationally for initial commercialization.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Immune TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    37 North Orange Ave, Suite 607, Orlando, FL 32801
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.immunetherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/immune-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biostax Corp Announces the Passing of Esteemed Director, H. Louis Salomonsky
    Biostax Corp Announces the Passing of Esteemed Director, H. Louis Salomonsky

    14 Sep 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/09/14/2743345/0/en/Biostax-Corp-Announces-the-Passing-of-Esteemed-Director-H-Louis-Salomonsky.html

    GLOBENEWSWIRE
    14 Sep 2023
    Share Share
    Biostax Corp. Signs CollabAgreement with Immgenuity to Pursue Remission in HIV
    Biostax Corp. Signs CollabAgreement with Immgenuity to Pursue Remission in HIV

    29 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/08/29/2733500/0/en/Biostax-Corp-Signs-Collaboration-Agreement-with-Immgenuity-Inc-to-Pursue-Remission-in-HIV.html

    GLOBENEWSWIRE
    29 Aug 2023
    Share Share
    Biostax Announces the FDAs Acceptance of Three IND Transfers for JKB-122
    Biostax Announces the FDAs Acceptance of Three IND Transfers for JKB-122

    15 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/08/15/2725553/0/en/Biostax-Corp-Announces-the-FDAs-Acceptance-of-Three-Investigational-New-Drug-Applications-IND-Transfers-for-JKB-122-for-the-Treatment-of-NASH-NAFLD-and-AIH.html

    GLOBENEWSWIRE
    15 Aug 2023
    Share Share
    Immune Therapeutics Announces Shareholder Approval Name Change to Biostax Corp
    Immune Therapeutics Announces Shareholder Approval Name Change to Biostax Corp

    01 Mar 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/03/01/2618375/0/en/Immune-Therapeutics-Inc-Announces-Shareholder-Approval-of-Name-Change-to-Biostax-Corp-and-Unveils-New-Website-Business-Strategies-and-Direction.html

    GLOBENEWSWIRE
    01 Mar 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search